
Sernova Biotherapeutics Investor Relations Material
Latest events

AGM 2024
Sernova Biotherapeutics

Q2 2025
12 Jun, 2025

Q1 2025
13 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sernova Biotherapeutics Inc
Access all reports
Sernova Corp is a biotechnology company focused on developing cell therapy solutions for the treatment of chronic diseases, including diabetes, hemophilia, and thyroid disorders. The company’s lead technology, the Cell Pouch System, is an implantable device designed to house therapeutic cells that can produce essential proteins or hormones, potentially offering a functional cure for diseases such as type 1 diabetes. The company is headquartered in London, Canada, and its shares are listed on the TSX and OTCQB.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SVA
Country
🇨🇦 Canada